John Nordberg

John Nordberg (he/him)Board Member

John Nordberg has been working in pharmaceutical, biotechnology, and medical device Quality for 25 years. His career spans roles with large pharmaceutical companies including Pfizer and Novartis, in addition to small development biotech. He is currently Executive Director, CMC Quality Assurance at Dianthus Therapeutics. John is based in Manhattan and serves as a Board Member of OUTbio: Greater New York.

John focuses on ensuring all aspects of investigational and commercial drug products meet regulatory and health authority quality requirements. He works closely with Regulatory Affairs, CMC, Medical Affairs, and Commercial organizations.

John received his MPH from the Boston University School of Public Health with concentrations in Epidemiology and Biostatistics and Health Policy & Law. While at BUSPH, John served as Public Health Fellow for the Massachusetts Legislature Joint Committee on Public Health.